Introduction The GLP‑1 revolution obesity drugs era is here. These glucagon‑like peptide‑1 receptor agonists (GLP‑1 RAs) are no longer niche diabetes treatments but the…
Africa’s pharmaceutical market is in the middle of a transformation. The sector is expected to grow from USD 27.43 billion in 2024 to USD 38.24 billion by 2033[1],…